Mo, C., Gasparetto, C., Costa, C., Cowan, A., Mark, T., Chai, Y., Kashyap, T., Katz, J., Amatangelo, M., Richardson, P. (2025). Selinexor, mezigdomide, and dexamethasone in patients with Relapsed/Refractory multiple myeloma who relapsed or are ineligible for T-cell–redirecting therapy: Stomp Phase 1 results. Blood. https://doi.org/10.1182/blood-2025-4010